126069-70-3 Usage
Description
Imidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2-(trifluoromethyl)(9CI) is a chemical compound belonging to the class of imidazo[1,2-a]pyrazines. It is characterized by its unique fused heterocycle structure and the presence of a trifluoromethyl group, which may contribute to its potential applications in various fields.
Uses
Used in Chemical Research:
Imidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2-(trifluoromethyl)(9CI) is used as a research compound for studying the synthesis and properties of fused heterocycle-linked triazole derivatives. Its unique structure allows for the exploration of new chemical reactions and the development of novel compounds with potential applications in various industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Imidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2-(trifluoromethyl)(9CI) may be used as a starting material or intermediate in the synthesis of new drugs. Its specific structural features could be exploited to design and develop innovative therapeutic agents with improved pharmacological properties.
Used in Material Science:
The compound may also find applications in material science, where its unique structural characteristics could be utilized to create new materials with specific properties, such as enhanced stability, reactivity, or selectivity in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 126069-70-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,0,6 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 126069-70:
(8*1)+(7*2)+(6*6)+(5*0)+(4*6)+(3*9)+(2*7)+(1*0)=123
123 % 10 = 3
So 126069-70-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H8F3N3/c8-7(9,10)5-4-13-2-1-11-3-6(13)12-5/h4,11H,1-3H2
126069-70-3Relevant articles and documents
BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Paragraph 0188, (2015/12/30)
The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
PHTHALAZINONE KETONE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL USE THEREOF
-
Paragraph 0114; 0116, (2013/06/28)
A phthalazinone ketone derivative as represented by formula (I), a preparation method thereof, a pharmaceutical composition containing the derivative, a use thereof as a poly (ADP-ribose) polymerase (PARP) inhibitor, and a cancer treatment method thereof.
5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
-
Page/Page column 51-52, (2010/11/17)
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2/s